153 related articles for article (PubMed ID: 6089937)
21. Inhibitors of Na+/H+ exchange block epinephrine- and ADP-induced stimulation of human platelet phospholipase C by blockade of arachidonic acid release at a prior step.
Sweatt JD; Blair IA; Cragoe EJ; Limbird LE
J Biol Chem; 1986 Jul; 261(19):8660-6. PubMed ID: 3013858
[TBL] [Abstract][Full Text] [Related]
22. Effects of trifluoperazine on platelet activation.
Ardlie NG; Boatwright C; Garrett J; McGuiness JA
Thromb Res; 1985 Jun; 38(6):695-706. PubMed ID: 3161211
[TBL] [Abstract][Full Text] [Related]
23. Effects of heparin on platelet aggregation and release and thromboxane A2 production.
Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG
Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300
[TBL] [Abstract][Full Text] [Related]
24. Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors.
Jin J; Quinton TM; Zhang J; Rittenhouse SE; Kunapuli SP
Blood; 2002 Jan; 99(1):193-8. PubMed ID: 11756171
[TBL] [Abstract][Full Text] [Related]
25. Enrichment of human platelet phospholipids with linoleic acid diminishes thromboxane release.
Needleman SW; Spector AA; Hoak JC
Prostaglandins; 1982 Nov; 24(5):607-22. PubMed ID: 6819602
[TBL] [Abstract][Full Text] [Related]
26. Dissociation between the phospholipases C and A2 activities in stimulated platelets and their involvement in the arachidonic acid liberation.
Faili A; Emadi S; Vargaftig BB; Hatmi M
Br J Haematol; 1994 Sep; 88(1):149-55. PubMed ID: 7803237
[TBL] [Abstract][Full Text] [Related]
27. The inhibitory effects of exogenous arachidonic acid on rabbit platelet aggregation and the release reaction.
Cattaneo M; Kinlough-Rathbone RL; Perry DW; Chahil A; Vickers JD; Lam SC; Packham MA; Mustard JF
Blood; 1982 Nov; 60(5):1179-87. PubMed ID: 6289942
[TBL] [Abstract][Full Text] [Related]
28. A major role of ADP in thromboxane transfer experiments: studies in patients with platelet secretion defects.
Rao AK; Willis J; Holmsen H
J Lab Clin Med; 1984 Jul; 104(1):116-26. PubMed ID: 6429260
[TBL] [Abstract][Full Text] [Related]
29. Ethanol interferes with collagen-induced platelet activation by inhibition of arachidonic acid mobilization.
Rubin R
Arch Biochem Biophys; 1989 Apr; 270(1):99-113. PubMed ID: 2494946
[TBL] [Abstract][Full Text] [Related]
30. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
[TBL] [Abstract][Full Text] [Related]
31. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM
Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415
[TBL] [Abstract][Full Text] [Related]
32. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
Connolly TM; Limbird LE
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
[TBL] [Abstract][Full Text] [Related]
33. A new congenital defect of platelet secretion: impaired responsiveness of the platelets to cytoplasmic free calcium.
Hardisty RM; Machin SJ; Nokes TJ; Rink TJ; Smith SW
Br J Haematol; 1983 Apr; 53(4):543-57. PubMed ID: 6830700
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of 8-bromo cyclic GMP on an extracellular Ca2+-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets.
Matsuoka I; Nakahata N; Nakanishi H
Biochem Pharmacol; 1989 Jun; 38(11):1841-7. PubMed ID: 2544181
[TBL] [Abstract][Full Text] [Related]
35. Evidence for a role for Galphai1 in mediating weak agonist-induced platelet aggregation in human platelets: reduced Galphai1 expression and defective Gi signaling in the platelets of a patient with a chronic bleeding disorder.
Patel YM; Patel K; Rahman S; Smith MP; Spooner G; Sumathipala R; Mitchell M; Flynn G; Aitken A; Savidge G
Blood; 2003 Jun; 101(12):4828-35. PubMed ID: 12609843
[TBL] [Abstract][Full Text] [Related]
36. Altered platelet function in cirrhosis of the liver: impairment of inositol lipid and arachidonic acid metabolism in response to agonists.
Laffi G; Cominelli F; Ruggiero M; Fedi S; Chiarugi VP; La Villa G; Pinzani M; Gentilini P
Hepatology; 1988; 8(6):1620-6. PubMed ID: 3142812
[TBL] [Abstract][Full Text] [Related]
37. Secretory phospholipase A2 is not required for arachidonic acid liberation during platelet activation.
Mounier C; Faili A; Vargaftig BB; Bon C; Hatmi M
Eur J Biochem; 1993 Aug; 216(1):169-75. PubMed ID: 8365403
[TBL] [Abstract][Full Text] [Related]
38. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
[TBL] [Abstract][Full Text] [Related]
39. Effects of ethanol on pathways of platelet aggregation in vitro.
Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
[TBL] [Abstract][Full Text] [Related]
40. Pathways responsible for platelet hypersensitivity in rats with diabetes. II. Spontaneous diabetes in BB Wistar rats.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):154-8. PubMed ID: 3080539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
